FR2689763B1 - Agent pour la prévention et l'inhibition de la réaction de Maillard comprenant un composé d'organogermanium utile pour le traitement du diabète. - Google Patents

Agent pour la prévention et l'inhibition de la réaction de Maillard comprenant un composé d'organogermanium utile pour le traitement du diabète.

Info

Publication number
FR2689763B1
FR2689763B1 FR9303000A FR9303000A FR2689763B1 FR 2689763 B1 FR2689763 B1 FR 2689763B1 FR 9303000 A FR9303000 A FR 9303000A FR 9303000 A FR9303000 A FR 9303000A FR 2689763 B1 FR2689763 B1 FR 2689763B1
Authority
FR
France
Prior art keywords
diabetes
inhibiting
preventing
agent
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9303000A
Other languages
English (en)
French (fr)
Other versions
FR2689763A1 (fr
Inventor
Norihiro Kakimoto
Kunie Nakamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asai Germanium Research Institute Co Ltd
Original Assignee
Asai Germanium Research Institute Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asai Germanium Research Institute Co Ltd filed Critical Asai Germanium Research Institute Co Ltd
Publication of FR2689763A1 publication Critical patent/FR2689763A1/fr
Application granted granted Critical
Publication of FR2689763B1 publication Critical patent/FR2689763B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/30—Germanium compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
FR9303000A 1992-03-16 1993-03-16 Agent pour la prévention et l'inhibition de la réaction de Maillard comprenant un composé d'organogermanium utile pour le traitement du diabète. Expired - Fee Related FR2689763B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4091685A JPH05255130A (ja) 1992-03-16 1992-03-16 メイラード反応抑制改善剤

Publications (2)

Publication Number Publication Date
FR2689763A1 FR2689763A1 (fr) 1993-10-15
FR2689763B1 true FR2689763B1 (fr) 1995-04-28

Family

ID=14033361

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9303000A Expired - Fee Related FR2689763B1 (fr) 1992-03-16 1993-03-16 Agent pour la prévention et l'inhibition de la réaction de Maillard comprenant un composé d'organogermanium utile pour le traitement du diabète.

Country Status (11)

Country Link
US (1) US5352815A (OSRAM)
JP (1) JPH05255130A (OSRAM)
KR (1) KR100245571B1 (OSRAM)
AU (1) AU659589B2 (OSRAM)
CA (1) CA2091651C (OSRAM)
CH (1) CH685876A5 (OSRAM)
DE (1) DE4308374C2 (OSRAM)
FR (1) FR2689763B1 (OSRAM)
GB (1) GB2265547B (OSRAM)
IT (1) IT1271438B (OSRAM)
TW (1) TW278036B (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH1143432A (ja) * 1997-07-25 1999-02-16 Biremo Sci:Kk 脳の老化抑制及び治療剤
CA2339879C (en) 1998-08-24 2011-11-15 Toshio Miyata Carbonyl-stress improving agent and peritoneal dialysate

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1365997A (en) * 1972-05-25 1974-09-04 Asai K Medicament comprising an organo germanium sesquioxide compound
JPS5632485A (en) * 1979-08-24 1981-04-01 Pola Chem Ind Inc Preparation of organogermanium compound
DE3212817A1 (de) * 1982-04-06 1983-10-13 Sanum-Kehlbeck GmbH & Co KG, 2812 Hoya Pharmazeutisch wirksame organische germaniumverbindungen und verfahren zu deren herstellung
JPS601317B2 (ja) * 1982-08-23 1985-01-14 紀博 柿本 親水性及び親油性を併せ有する有機ゲルマニウム化合物
JPS6041472A (ja) * 1983-08-16 1985-03-05 Refuorumu Syst Kk 美容・健康飲料
JPS60226592A (ja) * 1984-04-25 1985-11-11 Asai Gerumaniumu Kenkyusho:Kk 抗酸化剤
JPS61145115A (ja) * 1984-12-18 1986-07-02 Asai Gerumaniumu Kenkyusho:Kk 塵肺症患者用風邪症候群予防剤
JPS63107920A (ja) * 1986-06-18 1988-05-12 Asai Gerumaniumu Kenkyusho:Kk 骨芽細胞活性化剤
US4973553A (en) * 1987-09-09 1990-11-27 Asai Germanium Research Institute Salt or organogermanium compound and medicine containing the same
JP2698870B2 (ja) * 1987-10-29 1998-01-19 株式会社浅井ゲルマニウム研究所 シクロスポリンの投与による腎毒性の軽減剤
CA1314210C (en) * 1987-10-29 1993-03-09 Norihiro Kakimoto Agent for improving reduced functions of organs caused by inhibited blood circulation
JPH01149723A (ja) * 1987-12-07 1989-06-12 Asai Gerumaniumu Kenkyusho:Kk 骨芽細胞活性化剤
JP2652556B2 (ja) * 1988-08-29 1997-09-10 株式会社浅井ゲルマニウム研究所 有機ゲルマニウム化合物及びその製造方法
EP0404062A3 (en) * 1989-06-20 1991-09-25 Sanwa Kagaku Kenkyusho Co., Ltd. Organogermanium compound, process for preparation of same as well as use thereof
AU635045B2 (en) * 1989-07-20 1993-03-11 Asai Germanium Research Institute Co., Ltd Agent for preventing and treating opacity of lens
JPH03251526A (ja) * 1990-02-28 1991-11-11 Sanwa Kagaku Kenkyusho Co Ltd 糖尿病依存型自己免疫疾患治療、予防用薬剤

Also Published As

Publication number Publication date
CA2091651C (en) 2003-09-23
AU659589B2 (en) 1995-05-18
GB2265547A (en) 1993-10-06
CA2091651A1 (en) 1993-09-17
JPH05255130A (ja) 1993-10-05
FR2689763A1 (fr) 1993-10-15
GB2265547B (en) 1996-07-31
AU3511893A (en) 1993-09-23
CH685876A5 (fr) 1995-10-31
GB9305309D0 (en) 1993-05-05
IT1271438B (it) 1997-05-28
TW278036B (OSRAM) 1996-06-11
KR100245571B1 (ko) 2000-03-02
US5352815A (en) 1994-10-04
DE4308374C2 (de) 2002-01-03
DE4308374A1 (de) 1993-10-07
ITMI930491A0 (it) 1993-03-15
KR930019210A (ko) 1993-10-18
ITMI930491A1 (it) 1994-09-15

Similar Documents

Publication Publication Date Title
SG80530A1 (en) Pharmaceutical combination for the treatment of prostatic hyperplasia, containing a 5 alpha-reductase inhibitor and an antiandrogen
DE3881443D1 (de) Imidazol-verbindung und diese enthaltende biozide zusammensetzungen.
ZA9610543B (en) Compounds and compositions for reducing blood glucose and/or inhibiting the activity of CGRP.
ZA93323B (en) Preparation of fluorinated functional compounds.
IL102571A0 (en) Pharmaceutical composition for the treatment of heart failure containing an inhibitor of neutral endopeptidase
IT1150865B (it) Dispositivi allo stato solido prodotti mediante sviluppo di plasma di "resists"
EP0567088A3 (en) Process for the preparation of an amylase inhibitor.
AU1893492A (en) Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor
MA22946A1 (fr) Compositions de precurseurs d'agents de blanchiment.
ITMI922961A0 (it) Procedimento per la dealogenazione chimica di composti organici alogenati.
ITMI921308A0 (it) Catalizzatore metallico supportato per l'idrogenazione di composti organici e suo procedimento di preparazione
TW325997B (en) Pharmaceutical composition for preventing and treating retinal diseases
DE69310155D1 (de) Perfluoralkylierung aromatischer verbindungen
IT8348031A0 (it) Composizione farmaceutica contenente un composto di 1,4-benzochinone e suo impiego come agente antifibro tico
NO933892D0 (no) Fremgangsmaate for behandling av metallkloridinneholdende avfall
EP0649308A4 (en) PREVENTION OF HEMOLYSIS.
KR950700738A (ko) 당뇨병 치료를 위한 퀴놀린-3-카르복시아미드 화합물의 용도(the use of quinoline-3-carboxamide compounds for treatment of diabetes)
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
IT8422394A0 (it) Procedimento per il trattamento e/o l'immagazzinamento di residui industriali.
IL106064A (en) Gallium complexes for the treatment of free radical-induced diseases
IT7925203A0 (it) Procedimento per il trattamento di correnti effluenti contenenti nitrofenoli.
BE892339A (fr) Agents pour le traitement d'affections cardiaques coronariennes
FR2692261B1 (fr) Procédé de préparation d'un télogène actif.
ZA93348B (en) Treatment of liquids.
AU7850491A (en) Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20121130